[Therapy of myasthenia gravis in pregnancy].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000549:Ambenonium Chloride / Q000627:therapeutic use; D001285:Atropine / Q000627:therapeutic use; D004491:Edrophonium / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009157:Myasthenia Gravis / Q000188:drug therapy*; D009388:Neostigmine / Q000627:therapeutic use; D011189:Potassium Chloride / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011729:Pyridostigmine Bromide / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D009388:Neostigmine; D000549:Ambenonium Chloride; D011189:Potassium Chloride; D004491:Edrophonium; D001285:Atropine; D000324:Adrenocorticotropic Hormone; D011729:Pyridostigmine Bromide
La terapia della miastenia grave durante la gravidanza.